Fieldpoint Private Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-687
Closed -$66K 1680
2021
Q3
$66K Hold
687
0.01% 509
2021
Q2
$66K Sell
687
-8
-1% -$955 0.01% 514
2021
Q1
$92K Sell
695
-202
-23% -$27.6K 0.02% 415
2020
Q4
$119K Buy
+897
New +$108K 0.03% 369
2020
Q1
Sell
-784
Closed -$72K 351
2019
Q4
$72K Buy
+784
New +$68.9K 0.02% 369

Other funds holding EXAS

Fieldpoint Private Securities's EXAS Position: Q4 2021 in Review

Fieldpoint Private Securities sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 687 shares — an estimated $66K sold.

Fieldpoint Private Securities first reported a position in EXAS in Q4 2019 and held it in 5 quarters. The position peaked at $119K in Q4 2020. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Fieldpoint Private Securities reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Fieldpoint Private Securities sold 687 Exact Sciences shares in Q4 2021, an estimated $66K.
  • Fieldpoint Private Securities first reported a position in Exact Sciences in Q4 2019 and held it in 5 quarters.
  • Fieldpoint Private Securities's Exact Sciences position peaked at $119K in Q4 2020.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Fieldpoint Private Securities's 13F filing for Q4 2021, filed 24 Jan 2022.